BCL2 and Alzheimer disease: In this regard, Rohn and colleagues have shown that overexpression of the anti apoptotic protein Bcl-2 in the context of a triple transgenic AD mouse model results in lack of pathology, highlighting the contribution of caspases in disease progression [56].